CSIMarket
 

Innovation1 Biotech Inc   (MYYZ)

Innovation1 Biotech Inc 's

Competitiveness




 

MYYZ Sales vs. its Competitors Q2 2024



Comparing the current results to its competitors, Innovation1 Biotech Inc reported Revenue decrease in the 2 quarter 2024 year on year by 0 %, despite the revenue increase by the most of its competitors of 0.62 %, recorded in the same quarter.

List of MYYZ Competitors





Revenue Growth Comparisons




Net Income Comparison


Innovation1 Biotech Inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<<  MYYZ Stock Performance Comparisons



*Market share is calculated based on total revenue.





Publicly Traded Peers of Innovation1 Biotech Inc




Timber Pharmaceuticals Inc
Share Performance



-87.33%
30 Days



Timber Pharmaceuticals Inc
Profile

Timber Pharmaceuticals Inc is a pharmaceutical company that operates on a business model centered around the research and development of innovative therapeutics. They focus on identifying and advancing novel treatments for various dermatological conditions. By leveraging their expertise in drug development, Timber Pharmaceuticals aims to bring safe and effective medications to market to address the unmet needs in dermatology.

More about Timber Pharmaceuticals Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1.056 mill. $ 0.016 mill. $ -14.935 mill.


Novartis Ag
Share Performance



+7.66%
One Year



Novartis Ag
Profile

Novartis AG's business model is centered around the development, manufacturing, and marketing of innovative pharmaceutical products.

More about Novartis Ag's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 268,773.400 mill. $ 70,725.000 mill. $ 17,991.000 mill.


Sanofi
Share Performance



-11.42%
This Year



Sanofi
Profile

Sanofi's business model revolves around the development, production, and distribution of pharmaceutical products. They aim to innovate and provide healthcare solutions across various therapeutic areas to improve patients' lives worldwide. Sanofi collaborates with partners and healthcare professionals to ensure effective delivery of their products and to address evolving patient needs.

More about Sanofi's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 104,715.264 mill. $ 52,321.040 mill. $ 8,793.120 mill.


Astrazeneca Plc
Share Performance



+0.56%
30 Days



Astrazeneca Plc
Profile

AstraZeneca Plc is a global biopharmaceutical company focused on the research, development, and commercialization of innovative medicines. Their business model involves investing extensively in research and development to discover novel treatments for a wide range of diseases. AstraZeneca then markets and sells these medicines globally, collaborating with healthcare providers and leveraging their strong sales and distribution networks.

More about Astrazeneca Plc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 124,678.840 mill. $ 73,196.000 mill. $ 12,681.000 mill.


Viatris Inc
Share Performance



+2.82%
This Quarter



Viatris Inc
Profile

Viatris Inc operates as a global pharmaceutical company, specializing in the development, manufacturing, and distribution of a wide range of generic and branded medicines, as well as biosimilars.

More about Viatris Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 19,054.854 mill. $ 14,737.300 mill. $ -410.700 mill.

147 more competitors available

Sign in to see all competitors

Sources: Innovation1 Biotech Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Innovation1 Biotech Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.